icon-folder.gif   Conference Reports for NATAP  
 
  HIV Glasgow 2026
8-11 November
Back grey_arrow_rt.gif
 
 
 
Metabolic and Liver Outcomes Through Week 48 Following Switch to Dolutegravir/Lamivudine in Older, ART-Experienced Adults: The Phase 3b EYEWITNESS Study
 
 
  Glasgow 2026 Nov 8-11
 

1109261copy

1109262copy

1109263copy

1109264copy

1109265copy

1109266copy

1109267copy

1109268copy